BrainsWay Signs Exclusive Distribution Agreement with Gaelan Medical Trade LLC
25 janv. 2021 08h00 HE
|
BrainsWay
CRESSKILL, N.J. and JERUSALEM, Jan. 25, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of...
BrainsWay Reports Third Quarter 2020 Financial Results and Operational Highlights
18 nov. 2020 07h00 HE
|
BrainsWay
CRESSKILL, N.J. and JERUSALEM, Israel, Nov. 18, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive...
BrainsWay to Report Third Quarter 2020 Financial Results and Operational Highlights on November 18, 2020
04 nov. 2020 07h00 HE
|
BrainsWay
CRESSKILL, N.J. and JERUSALEM, Nov. 04, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive treatment of...
BrainsWay to Participate in Two Upcoming Investor Conferences
02 nov. 2020 08h00 HE
|
BrainsWay
CRESSKILL, N.J. and JERUSALEM, Israel, Nov. 02, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive...
BrainsWay Debuts “#TheRealOCD” Campaign and Video on Obsessive-Compulsive Disorder (OCD)
13 oct. 2020 09h00 HE
|
BrainsWay
CRESSKILL, N.J., Oct. 13, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive treatment of brain disorders,...
BrainsWay’s Deep TMS Takes Center Stage at Clinical TMS Society Annual Poster Session
06 oct. 2020 09h00 HE
|
BrainsWay
CRESSKILL, N.J. and JERUSALEM, Israel, Oct. 06, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive...
BrainsWay Announces Presentations at Upcoming Investor Conferences
02 sept. 2020 07h00 HE
|
BrainsWay
CRESSKILL, N.J. and JERUSALEM, Sept. 02, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of...
BrainsWay Receives FDA Clearance for Smoking Addiction in Adults
24 août 2020 07h00 HE
|
BrainsWay
Company Intends to Execute a Controlled U.S. Market Release in Early 2021 This is the Company’s third FDA-cleared indication for its Deep TMS System, and is the first FDA clearance in the addiction...
BrainsWay Reports Second Quarter 2020 Financial Results and Operational Highlights
12 août 2020 07h00 HE
|
BrainsWay
CRESSKILL, N.J. and JERUSALEM, Israel, Aug. 12, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive...
BrainsWay to Participate in Virtual Conferences Elevate by Psych Congress Virtual Experience and Online Obsessive-Compulsive Disorder (OCD) in July 2020
21 juil. 2020 09h00 HE
|
BrainsWay Ltd.
PATTERSON, N.J., July 21, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive treatment of brain disorders,...